Protalex autoimmune disease treatment enters phase I testing
Assuming the success of the safety and tolerability phase of the testing process, the company plans to begin trials evaluating the efficacy of the compound in mid-2006. “This
Assuming the success of the safety and tolerability phase of the testing process, the company plans to begin trials evaluating the efficacy of the compound in mid-2006. “This
Boston Scientific is proposing to pay $72 per Guidant share in a combination of cash and stock, a price which is approximately 14% higher than the $63.43 value
The phase I/II trial is being initiated at The University of Texas MD Anderson Cancer Center, and is the first time researchers will be able to test the
The compound is a tumor necrosis factor alpha (TNF-alpha) antagonist for rheumatoid arthritis (RA) derived from Borean’s proprietary C-Type Lectin Domain (CTLD) library of therapeutic proteins. The study
The patent covers the core of the Oriel technology including design of Oriel’s dry powder inhalers containing multi-dose dry powder packages that can individually be activated to vibrate
Ribavirin is a synthetic nucleoside analogue with antiviral activity currently marketed by Roche Pharmaceuticals under the brand name Copegus. Annual US sales of the product are approximately $200
The study evaluated more than 1,700 Alzheimer’s cases and more than 1,700 age-matched controls. Results demonstrated that single nucleotide polymorphisms (SNPs) in a gene that is homologous to
Merck has submitted its license application for Gardasil as a vaccine to protect against four types of human papillomavirus (HPV), the sexually transmitted virus responsible for the majority
The investigational hepatitis C virus (HCV) treatment is a protease inhibitor, which will be studied during a 28-day investigation to evaluate its safety, tolerability and pharmacodynamics when combined
The Nervana System is a search and indexing tool that uses a proprietary, semantically intelligent search technology instead of basic keyword tools, and allows users to capture simultaneously